ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 22.82 thousand shares for the 1-month period ending 2021-01-28, per its 10-K filed 2022-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2022-03-30
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-06-30 was 0.00 shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-03-31 was 0.00 shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-12-31 was 8.96M shares, a 20106.97% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 1.91M shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2019 was 10.87M shares, a 2724.05% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 384.87K shares, a 81.82% decline from fiscal 2017.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 2.12M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|---|---|
| 2021-01-28 | 22.82K shares 10-K · filed 2022-03-30 | |||||
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 0.00 shares 10-Q · filed 2020-08-14 | 8.96M shares derived: sum of 3 quarters · filed 2020-08-14 | 10.87M shares derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2020-04-09 | 674.02K shares 10-K · filed 2022-03-30 | |||||
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 | 8.96M shares derived: sum of 2 quarters · filed 2020-05-14 | 10.87M shares derived: sum of 3 quarters · filed 2020-05-14 | 10.87M shares derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-12-31 | 8.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 10.87M shares derived: sum of 2 quarters · filed 2020-03-26 | 10.87M shares derived: sum of 3 quarters · filed 2020-03-26 | 10.87M shares 10-K · filed 2020-03-26 | ||
| 2019-09-30 | 1.91M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 1.91M shares derived: sum of 2 quarters · filed 2019-11-13 | 1.91M shares 10-Q · filed 2019-11-13 | 1.95M shares derived: sum of 4 quarters · filed 2019-11-13 | ||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | 44.33K shares derived: sum of 3 quarters · filed 2019-08-08 | 44.33K shares derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-14 | 44.33K shares derived: sum of 2 quarters · filed 2019-05-14 | 44.33K shares derived: sum of 3 quarters · filed 2019-05-14 | 364.87K shares derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2018-12-31 | 44.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | 44.33K shares derived: sum of 2 quarters · filed 2019-03-11 | 364.87K shares derived: sum of 3 quarters · filed 2019-03-11 | 384.87K shares 10-K · filed 2019-03-11 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | 320.54K shares derived: sum of 2 quarters · filed 2018-11-05 | 340.54K shares 10-Q · filed 2018-11-05 | 360.54K shares derived: sum of 4 quarters · filed 2018-11-05 | ||
| 2018-06-30 | 320.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 340.54K shares 10-Q · filed 2018-08-13 | 360.54K shares derived: sum of 3 quarters · filed 2018-08-13 | 360.54K shares derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2018-03-31 | 20.00K shares 10-Q · filed 2018-05-15 | 40.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 40.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 2.14M shares derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2017-12-31 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | 20.00K shares derived: sum of 2 quarters · filed 2018-03-20 | 2.12M shares derived: sum of 3 quarters · filed 2018-03-20 | 2.12M shares 10-K · filed 2018-03-20 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 2.10M shares derived: sum of 2 quarters · filed 2017-11-14 | 2.10M shares 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | 2.10M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 2.10M shares 10-Q · filed 2017-08-07 | ||||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |